MedWatch

Bavarian's market value up USD 1bn over three days

Over the course of three days, Bavarian Nordic has seen its share price increase by around DKK 100 (USD 14.3).

Photo: TIMOTHY A. CLARY/AFP / AFP

Everyone wants a slice of Bavarian Nordic following the widely reported small outbreak of monkeypox in a number of countries around the world.

This has turned the spotlight on Bavarian, which has the only approved vaccine against the disease – and which signed a supply deal with an undisclosed European country last week.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs